MARKET INTRODUCTION

Irritable bowel syndrome (IBS) diagnostics is done through medical history, physical exam and imaging tests. However, IBS is majorly diagnose by lactose intolerance tests, breath test for bacterial overgrowth, and stool test. The tests are done based on the symptoms such as constipation-predominant, diarrhea-predominant or mixed.

MARKET DYNAMICS

The irritable bowel syndrome (IBS) diagnostics market growth is anticipated to grow due to increasing geriatric population, growing unhealthy dietary habits, and increasing technologies to test chronic diseases. The market is expected to have growth opportunities owing to growing developments in the healthcare systems in developing regions that has enabled to improve diagnostics abilities.

MARKET SCOPE

The "Irritable bowel syndrome (IBS) diagnostics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of irritable bowel syndrome (IBS) diagnostics market with detailed market segmentation by diagnosis and indication. The irritable bowel syndrome (IBS) diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in irritable bowel syndrome (IBS) diagnostics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The irritable bowel syndrome (IBS) diagnostics market is segmented on the basis of, diagnosis and indication. Based on diagnosis, the market is divided into laboratory tests, and imaging tests. Based on indication, the market is classified as pain and cramping, diarrhea, constipation, and alternating constipation and diarrhea.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the irritable bowel syndrome (IBS) diagnostics market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The irritable bowel syndrome (IBS) diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting irritable bowel syndrome (IBS) diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the irritable bowel syndrome (IBS) diagnostics market in these regions.

MARKET PLAYERS

The report covers key developments in the irritable bowel syndrome (IBS) diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from irritable bowel syndrome (IBS) diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for irritable bowel syndrome (IBS) diagnostics in the global market. Below mentioned is the list of few companies engaged in the irritable bowel syndrome (IBS) diagnostics market.

The report also includes the profiles of key players in irritable bowel syndrome (IBS) diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Commonwealth Diagnostics International, Inc.
- Genova Diagnostics
- Gemelli Biotech
- Prometheus Laboratories Inc
- Biomerica Inc
- Inova Diagnostics
- Sysmex Europe GmbH
- B?hlmann Laboratories
- Metabolic Solutions, Inc.
- Aerodiagnostics